Press Releases

April 8, 2004

New CRM Technologies For Pharmaceutical Industry

Research Report From MindBranch Details CRM Opportunities For Pharmaceutical Companies

Williamstown, MA, April 8, 2004 - MindBranch, Inc., a leading provider of market research products and services, revealed today that a new research report is helping the pharmaceutical industry understand the ROI of analytical CRM technology. According to Datamonitor Publications, their new title, Analytical CRM: New Techologies for the Pharmaceutical Industry, is a must read for professionals seeking CRM tactics.

The report examines the CRM process, its benefits to pharmaceutical companies and the factors driving its use in the pharmaceutical industry today. It states that pharmaceutical companies will continue to invest in Analytical and Operational CRM. However, weaknesses in infrastructure and channels must be addressed if returns on ACRM are to be maximized over the longer term. The research includes implementation rates and a profile of key vendors including E.piphany, Microsoft, Oracle, SAS and Siebel.

For further information about this study, including a full table of contents and description information, please visit mindbranch.com

About MindBranch®, Inc.

MindBranch, founded in 1992, is a market research services company providing research from 300 leading publishers such as Reuters Business Insight, Frost & Sullivan, The Freedonia Group and Datamonitor Publications. Clients benefit from using a single, objective resource for their research needs. MindBranch distributes market research reports, newsletters, directories, subscriptions, and custom research in over 130 industry segments. For more information visit www.mindbranch.com or call 1-800-774-4410 or 1-413-458-7600.